ZL
Publicaties op Oncologisch.com
600- vs 400-mg Eerstelijns Ribociclib in Hormone Receptor-Positive/ERBB2-Negative Gevorderd Breast Cancer: The AMALEE...
Ribociclib Plus Endocrine Therapy in Hormone Receptor-Positive/ERBB2-Negative Early Breast Cancer: 4-Year Outcomes Fr...
Health-Related Quality of Life in Patients with HR+/HER2- Early Breast Cancer Treated with Ribociclib Plus a Nonstero...
Ribociclib plus endocriene therapie bij vroeg mammacarcinoom: NATALEE fase III